Abstract
Acute renal failure, now termed acute kidney injury (AKI), is a common occurrence in the pediatric intensive care unit. It impacts the management decisions and outcomes of critically ill patients. This chapter will review the factors involved in measuring renal function in children and recognizing abnormal renal function. The major clinical subtypes of AKI and how to distinguish between them will be addressed as well as some of the more common causes within each subtype. Management of AKI will be reviewed, including the indications for renal replacement therapy. The impact of impairment of renal function on the overall management and outcome of the critically ill pediatric patient will be discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Askenazi DJ, Ambalavanan N, Goldstein SL. Acute kidney injury in critically ill newborns: what do we know? What do we need to learn? Pediatr Nephrol. 2009;24:265–74.
Barletta GM, Bunchman TE. Acute renal failure in children and infants. Curr Opin Crit Care. 2004;10:499–504.
Bhat MA, Shah ZA, Makhdoomi MS, Mufti MH. Theophylline for renal function in term neonates with perinatal asphyxia: a randomized, placebo-controlled trial. J Pediatr. 2006;149:180–4.
Bunchman TE, McBryde KD, Mottes TE, et al. Pediatric acute renal failure: outcome by modality and disease. Pediatr Nephrol. 2001;16:1067–71.
Cantarovich MD, Rangoonwala B, Lorenz H, et al. High-dose furosemide for established ARF: a prospective, randomized, double-blind, placebo-controlled, multicenter trial. Am J Kidney Dis. 2004;44:402–9.
Carvounis CP, Nisar S, Guro-Razuman S. Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure. Kidney Int. 2002;62:2223–9.
Cook KM, Gillon J, Grisso AG, et al. Incidence of nephrotoxicity among pediatric patients receiving vancomycin with either piperacillin–tazobactam or cefepime: a cohort study. J Pediatric Infect Dis Soc. 2019;8:221–7.
Devarajan P. The future of pediatric acute kidney injury management–biomarkers. Semin Nephrol. 2008;28:493–8.
Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis. 2002;40:221–6.
Diskin CJ, Stokes TJ, Dansby LM, Radcliff L, Carter TB. The comparative benefits of the fractional excretion of urea and sodium in various azotemic oliguric states. Nephron Clin Pract. 2010;114:145–50.
Drukker A, Guignard JP. Renal aspects of the term and preterm infant: a selective update. Curr Opin Pediatr. 2002;14:174–82.
Durmaz I, Yagdi T, Calkavur T, et al. Prophylactic dialysis in patients with renal dysfunction undergoing on-pump coronary artery bypass surgery. Ann Thorac Surg. 2003;75:859–64.
Foland JA, Fortenberry JD, Warshaw BL, et al. Fluid overload before continuous hemofiltration and survival in critically ill children: a retrospective analysis. Crit Care Med. 2004;32:1771–6.
Galley HF. Renal-dose dopamine: will the message now get through? Lancet. 2000;356:2112–3.
Goldstein SL. Fluid management in acute kidney injury. J Intensive Care Med. 2014;29:183–9.
Goldstein SL, Currier H, Graf CD, et al. Outcome in children receiving continuous venovenous hemofiltration. Pediatrics. 2001;107:1309–12.
Greenberg JH, Parikh CR. Biomarkers for diagnosis and prognosis of AKI in children one size does not fit all. Clin J Am Soc Nephrol. 2017;12:1551–7.
Han WK, Bonventre JV. Biologic markers for the early detection of acute kidney injury. Curr Opin Crit Care. 2004;10:476–82.
Honore PM, Jacobs R, De Waele E, Spapen HD. Applying pharmacokinetic/pharmacodynamics principles for optimizing antimicrobial therapy during continuous renal replacement therapy. Anaesthesiol Intensive Ther. 2017;49:412–8.
Hoorn EJ. Intravenous fluids: balancing solutions. J Nephrol. 2017;30:485–92.
Hsu CW, Symons JM. Acute kidney injury: can we improve prognosis? Pediatr Nephrol. 2010;25:2401–12.
Hui-Stickle S, Brewer ED, Goldstein SL. Pediatric ARF: epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis. 2005;45:96–101.
Joannidid M, Druml W, Forni LG, et al. Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017. Intensive Care Med. 2017;43:730–49.
Kaddourah A, Basu RK, Bagshaw SM, Goldstein SL, AWARE Investigators. Epidemiology of acute kidney injury in critically ill children and young adults. N Engl J Med. 2017;376:11–20.
Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med. 2008;148:284–94.
KDIGO clinical practice guideline for acute kidney injury. Kidney Int. 2012;2(Suppl 1):19–22.
Knight EL, Verhave JC, Spiegleman D, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004;65:1416–21.
Kuiper JW, Groenveld ABJ, Slutsky AS, et al. Mechanical ventilation and acute renal failure. Crit Care Med. 2005;33:1408–15.
Kwiatkowski DM, Menon S, Krawczeski CD, et al. Improved outcomes with peritoneal dialysis catheter placement after cardiopulmonary bypass in infants. J Thorac Cardiovasc Surg. 2015;149:230–6.
Lameire N, Vanholder R. Pathophysiologic features and prevention of human and experimental acute tubular necrosis. J Am Soc Nephrol. 2001;12:S20–32.
Lameire N, Vanholder R, van Biesen W. Loop diuretics for patients with acute renal failure: helpful or harmful? JAMA. 2002;288:2599–601.
Lee SA, Cozzi M, Bush EL, Rabb H. Distant organ dysfunction in acute kidney injury: a review. Am J Kidney Dis. 2018;72:846–56.
McLaughlin GE, Abitbol CL. Reversal of oliguric tacrolimus nephrotoxicity in children. Nephrol Dial Transplant. 2005;20:1471–5.
Mehta RL, Pascual MT, Soroko S, et al. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA. 2002;288:2547–53.
Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA. 2004;291:2328–34.
Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365:1231–8.
Moffett BS, Goldstein SL. Acute kidney injury and increasing nephrotoxic-medication exposure in noncritically-ill children. Clin J Am Soc Nephrol. 2011;6:856–63.
Moghal NE, Brockelbank JT, Meadow SR. A review of acute renal failure in children: incidence, etiology and outcome. Clin Nephrol. 1998;49:91–5.
Ng DL, Schwartz GJ, Schneider MF, et al. Combination of pediatric and adult formulas yield valid glomerular filtration rate estimates in young adults with a history of pediatric chronic kidney disease. Kidney Int. 2018;94:170–7.
Prowle JR, Echeverri JE, Ligabo EV, et al. Fluid balance and acute kidney injury. Nat Rev Nephrol. 2010;6:107–15.
Riley AA, Watson M, Smith C, et al. Pediatric continuous renal replacement therapy: have practice changes changed outcomes? A large single-center ten-year retrospective evaluation. BMC Nephrol. 2018;19:268.
Rivers E, Nguyen B, Havstad S, Early Goal-Directed Therapy Collaborative Group, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368–77.
Safirstein RL. Acute renal failure: from renal physiology to the renal transcriptome. Kidney Int. 2004;66(suppl 91):S62–6.
Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med. 2004;351:159–69.
Schrier RW, Wang W, Poole B, et al. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest. 2004;114:5–14.
Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin N Am. 1987;34:571–90.
Shilliday IR, Quinn KJ, Allison ME. Loop diuretics in the management of acute renal failure: a prospective, double-blind, placebo-controlled, randomized study. Nephrol Dial Transplant. 1997;12:2592–6.
Solomon R, Grodon P, Manoukian SV, BOSS Trial Investigators, et al. Randomized trial of bicarbonate or saline study for the prevention of contrast-induced nephropathy in patients with CKD. Clin J Am Soc Nephrol. 2015;10:1519–24.
Sutherland SM, Zappitelli M, Alexander SR, et al. Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis. 2010;55:316–25.
Uber AM, Sutherland SM. Acute kidney injury in hospitalized children: consequences and outcomes. Pediatr Nephrol. 2020;35:213–20.
Uchino S, Doig GS, Bellomo R, et al. Diuretics and mortality in acute renal failure. Crit Care Med. 2004;32:1669–77.
van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359–67.
Veltri MA, Neu AM, Fivush BA, et al. Drug dosing during intermittent hemodialysis and continuous renal replacement therapy. Pediatr Drugs. 2004;6:45–65.
Williams DM, Sreedhar SS, Mickell JJ, et al. Acute kidney failure: a pediatric experience over 20 years. Arch Pediatr Adolesc Med. 2002;156:893–900.
Williams C, Borges K, Banh T, et al. Patterns of kidney injury in pediatric nonkidney solid organ transplant recipients. Am J Transplant. 2018;18:1481–8.
Wyatt CM, Camargo M, Coca SG. Prophylactic hydration to prevent contrast-induced nephropathy: much ado about nothing? Kidney Int. 2017;92:4–6.
Zappitelli M, Krawczeski CD, Devarajan P, et al. TRIBE-AKI consortium. Early postoperative serum cystatin C predicts severe acute kidney injury following pediatric cardiac surgery. Kidney Int. 2011;80:655–62.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Varade, W.S., Erkan, E. (2021). Acute Kidney Injury. In: Lucking, S.E., Maffei, F.A., Tamburro, R.F., Zaritsky, A. (eds) Pediatric Critical Care . Springer, Cham. https://doi.org/10.1007/978-3-030-53363-2_31
Download citation
DOI: https://doi.org/10.1007/978-3-030-53363-2_31
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-53362-5
Online ISBN: 978-3-030-53363-2
eBook Packages: MedicineMedicine (R0)